Cargando…
Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?
BACKGROUND: The use of hyperoncotic albumin (HA) for shock resuscitation is controversial given concerns about its cost, effectiveness, and potential for nephrotoxicity. We evaluated the association between early exposure to hyperoncotic albumin (within the first 48 h of onset of shock) and acute or...
Autores principales: | Udeh, Chiedozie I., You, Jing, Wanek, Matthew R., Dalton, Jarrod, Udeh, Belinda L., Demirjian, Sevag, Rahman, Nadeem, Hata, J. Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293561/ https://www.ncbi.nlm.nih.gov/pubmed/30564306 http://dx.doi.org/10.1186/s13741-018-0110-y |
Ejemplares similares
-
The evidence for small-volume resuscitation with hyperoncotic albumin in critical illness
por: Myburgh, John A
Publicado: (2008) -
Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants
por: Udeh, Belinda, et al.
Publicado: (2008) -
Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials
por: Jacob, Matthias, et al.
Publicado: (2008) -
Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients
por: O'Brien, Zachary, et al.
Publicado: (2022) -
Hyperoncotic albumin infusion in experimental glomerulonephritis in rats: A micropuncture study.
por: Allison, M. E., et al.
Publicado: (1975)